Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TFC | 39.77% | $52.72B | +9.37% | 5.25% |
BRKL | 39.27% | $944.51M | +26.19% | 5.13% |
CRNX | 39.11% | $3.03B | -32.34% | 0.00% |
SFBS | 39.07% | $4.09B | +22.47% | 1.71% |
FBK | 38.98% | $2.01B | +20.87% | 1.67% |
ZION | 38.48% | $7.22B | +15.27% | 3.51% |
FNB | 38.36% | $5.06B | +8.32% | 3.45% |
PPBI | 38.34% | $2.08B | -0.33% | 6.25% |
FHN | 38.29% | $10.12B | +33.07% | 3.04% |
FITB | 38.16% | $26.13B | +8.57% | 3.76% |
TFSL | 38.13% | $3.67B | +4.47% | 10.90% |
UBSI | 38.05% | $5.18B | +14.39% | 4.10% |
CLDX | 38.02% | $1.36B | -43.29% | 0.00% |
UCB | 38.00% | $3.54B | +16.45% | 3.28% |
HBNC | 37.89% | $667.63M | +26.48% | 4.26% |
BANC | 37.75% | $2.22B | +4.29% | 2.86% |
IBOC | 37.70% | $4.02B | +16.50% | 2.13% |
SNV | 37.61% | $6.81B | +30.48% | 3.17% |
ABCB | 37.51% | $4.31B | +28.65% | 1.13% |
BEAM | 37.49% | $1.80B | -31.35% | 0.00% |
Double maintains 2 strategies that include BCRX - BioCryst Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRESY | -0.01% | $662.59M | +30.16% | 5.56% |
PG | -0.02% | $380.07B | -1.86% | 2.51% |
SYPR | 0.05% | $44.35M | +2.66% | 0.00% |
SMCI | 0.05% | $25.79B | -44.23% | 0.00% |
SO | -0.08% | $98.42B | +14.16% | 3.23% |
TTEK | 0.08% | $9.39B | -16.39% | 1.31% |
CORT | -0.14% | $7.55B | +118.26% | 0.00% |
FMC | -0.21% | $5.49B | -23.29% | 5.37% |
CYD | -0.22% | $718.48M | +121.39% | 1.85% |
DUK | 0.27% | $90.43B | +14.83% | 3.58% |
LITB | -0.27% | $21.77M | -74.81% | 0.00% |
TEO | -0.31% | $1.20B | +35.84% | 0.00% |
AMT | 0.38% | $100.35B | +10.60% | 3.04% |
CME | 0.39% | $97.17B | +37.77% | 3.95% |
CCEC | 0.42% | $1.02B | +3.91% | 2.79% |
UFI | 0.47% | $96.58M | -8.68% | 0.00% |
SG | -0.48% | $1.54B | -61.40% | 0.00% |
CBOE | -0.60% | $23.34B | +31.58% | 1.12% |
KMB | 0.63% | $44.08B | -1.73% | 3.72% |
MERC | -0.64% | $250.10M | -56.56% | 8.11% |
Current Value
$10.551 Year Return
Current Value
$10.551 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KRBN | <0.01% | $159.86M | 0.85% |
ICSH | -0.02% | $6.16B | 0.08% |
ILTB | 0.03% | $587.66M | 0.06% |
KMLM | 0.04% | $191.60M | 0.9% |
USCI | -0.04% | $235.98M | 1.07% |
STIP | 0.05% | $12.59B | 0.03% |
AGZD | 0.06% | $110.81M | 0.23% |
DBC | -0.12% | $1.19B | 0.87% |
IBDZ | 0.13% | $343.47M | 0.1% |
TBIL | -0.14% | $5.91B | 0.15% |
TIPZ | 0.22% | $95.87M | 0.2% |
GTIP | -0.26% | $157.15M | 0.12% |
SCHI | 0.27% | $8.50B | 0.03% |
JSI | 0.30% | $833.00M | 0.49% |
IBMR | -0.33% | $250.36M | 0.18% |
CANE | -0.33% | $10.00M | 0.29% |
IBDV | 0.36% | $1.85B | 0.1% |
CTA | -0.38% | $1.09B | 0.76% |
HTAB | 0.40% | $409.24M | 0.39% |
GSG | -0.41% | $920.18M | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 47.34% | $4.99B | 0.35% |
PBE | 46.50% | $228.06M | 0.58% |
IBB | 44.03% | $5.26B | 0.45% |
GNOM | 43.44% | $44.85M | 0.5% |
XPH | 41.77% | $155.05M | 0.35% |
BBH | 39.84% | $338.76M | 0.35% |
PINK | 39.80% | $132.75M | 0.5% |
PTH | 39.55% | $105.01M | 0.6% |
IAT | 39.15% | $631.32M | 0.4% |
KRE | 38.80% | $3.44B | 0.35% |
IWC | 38.41% | $815.56M | 0.6% |
KBE | 38.35% | $1.38B | 0.35% |
KBWB | 38.31% | $3.94B | 0.35% |
VTWO | 37.36% | $12.43B | 0.07% |
FBT | 37.31% | $1.04B | 0.54% |
ARKG | 37.30% | $977.20M | 0.75% |
IWM | 37.27% | $63.71B | 0.19% |
GSSC | 37.04% | $557.11M | 0.2% |
IWN | 36.65% | $11.10B | 0.24% |
KJUL | 36.55% | $120.33M | 0.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -27.91% | $107.71M | 0.59% |
BTAL | -20.96% | $297.88M | 1.43% |
VIXY | -18.84% | $178.15M | 0.85% |
IBTG | -14.30% | $1.94B | 0.07% |
FTSD | -13.68% | $228.22M | 0.25% |
SPTS | -13.35% | $5.78B | 0.03% |
GBIL | -13.04% | $6.05B | 0.12% |
XHLF | -12.64% | $1.64B | 0.03% |
IBTI | -12.59% | $1.02B | 0.07% |
LGOV | -12.58% | $690.80M | 0.67% |
IBTM | -12.43% | $318.33M | 0.07% |
ULST | -12.21% | $667.10M | 0.2% |
IBTH | -12.00% | $1.57B | 0.07% |
SCHR | -11.93% | $10.64B | 0.03% |
IEI | -11.92% | $15.22B | 0.15% |
GOVT | -11.81% | $27.29B | 0.05% |
UTWO | -11.65% | $374.45M | 0.15% |
IBTK | -11.54% | $429.15M | 0.07% |
IBTJ | -11.47% | $669.37M | 0.07% |
AGZ | -11.43% | $607.98M | 0.2% |
Yahoo
Health care stocks were leaning lower premarket Friday with the Health Care Select Sector SPDR Fund
Yahoo
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older. “Today’s announcement marks another important step toward bringing ORLADEYO to people living with HAE who are
Finnhub
BioCryst Pharmaceuticals, Inc. announced that the National Institute of Drug and Food Surveillance in Colombia has granted approval for oral, once-daily ORLADEYO®? for the prophylaxis of hereditary...
Yahoo
United Therapeutics (UTHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Finnhub
Presenter SpeechRyan Fisk Welcome. Thrilled to have you all here at the Goldman Healthcare Conference for 2025. We are early in the conference. It's my great pleasure to be here with BioCryst with
SeekingAlpha
Discover how Eton Pharmaceuticals' 117% YoY rare-disease revenue growth has legs
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ZBH | -12.58% | $18.65B | -12.29% | 1.03% |
FMTO | -9.42% | $5.10K | -99.92% | 0.00% |
STG | -9.18% | $32.24M | -0.16% | 0.00% |
AIFU | -8.36% | $3.36B | 0.00% | 0.00% |
VHC | -7.25% | $37.77M | +135.71% | 0.00% |
VZ | -5.28% | $184.42B | +9.98% | 6.26% |
EXC | -5.27% | $43.29B | +23.40% | 3.60% |
AEP | -4.70% | $54.46B | +15.89% | 3.59% |
IART | -4.57% | $997.05M | -55.90% | 0.00% |
LFVN | -4.37% | $159.24M | +69.34% | 1.30% |
PRPO | -4.19% | $16.74M | +87.63% | 0.00% |
NEXA | -4.14% | $650.28M | -37.13% | 0.00% |
TSN | -3.92% | $19.34B | +1.17% | 3.60% |
AQB | -3.67% | $3.52M | -50.00% | 0.00% |
WBA | -3.24% | $9.81B | -27.03% | 4.41% |
PSQH | -3.21% | $107.02M | -32.86% | 0.00% |
CNP | -3.14% | $23.52B | +16.26% | 2.36% |
MKTX | -3.04% | $8.44B | +11.89% | 1.32% |
PEP | -2.91% | $178.10B | -20.71% | 4.18% |
CARV | -2.82% | $8.38M | -11.35% | 0.00% |